Structures by: Debache A.
Total: 12
C31H30NO3P
C31H30NO3P
Organic & biomolecular chemistry (2019) 17, 23 5789-5800
a=9.1640(12)Å b=10.0512(13)Å c=28.621(4)Å
α=90° β=90.278(5)° γ=90°
<i>N</i>-[(2-Hydroxynaphthalen-1-yl)(3-methylphenyl)methyl]acetamide
C20H19NO2
Acta Crystallographica Section E (2018) 74, 7 1002-1005
a=24.3079(16)Å b=7.5677(4)Å c=18.4555(14)Å
α=90° β=110.024(8)° γ=90°
(<i>Z</i>)-4-(4-Hydroxybenzylidene)-3-methylisoxazol-5(4<i>H</i>)-one
C11H9NO3
Acta Crystallographica Section E (2018) 74, 7 926-930
a=21.191(2)Å b=7.2352(11)Å c=12.9569(14)Å
α=90° β=103.920(11)° γ=90°
Diethyl 4-(4-bromophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
C19H22BrNO4
Acta Crystallographica Section E (2007) 63, 8 o3635-o3636
a=10.0597(5)Å b=7.4244(4)Å c=24.3726(13)Å
α=90.00° β=98.126(2)° γ=90.00°
Trans-3-(2-Chloro-3-quinolyl)-1-phenyl-2,3-epoxypropan-1-one
C18H12ClNO2
Acta Crystallographica Section E (2007) 63, 9 o3795-o3796
a=11.0782(19)Å b=9.6177(19)Å c=13.352(3)Å
α=90.00° β=96.511(9)° γ=90.00°
Ethyl 4-(2-chloroquinolin-3-yl)-1-phenyl-1<i>H</i>-pyrrole-3-carboxylate
C22H17ClN2O2
Acta Crystallographica Section E (2008) 64, 11 o2115-o2116
a=20.2021(6)Å b=8.05000(10)Å c=24.0238(7)Å
α=90.00° β=105.29(2)° γ=90.00°
<i>N</i>-[(2-Chloro-8-methylquinolin-3-yl)methyl]-4-methoxyaniline
C18H17ClN2O
Acta Crystallographica Section E (2010) 66, 11 o2856-o2857
a=7.30670(10)Å b=17.7803(4)Å c=22.8221(5)Å
α=90° β=90° γ=90°
Diethyl 2,6-dimethylpyridine-3,5-dicarboxylate
C13H17N1O4
Acta Crystallographica Section E (2009) 65, 10 o2528
a=4.5380(6)Å b=15.440(2)Å c=18.722(2)Å
α=90.00° β=90.502(6)° γ=90.00°
2-Hydroxy-<i>N</i>-(4-methoxybenzyl)-4-nitroanilinium chloride
C14H15N2O4,Cl
Acta Crystallographica Section E (2011) 67, 8 o2164-o2165
a=32.1166(9)Å b=7.4888(2)Å c=13.0907(4)Å
α=90° β=108.655(2)° γ=90°
2-(2-Chloro-8-methylquinolin-3-yl)-4-phenyl-1,2-dihydroquinazoline
C24H18ClN3
Acta Crystallographica Section E (2013) 69, 11 o1719-o1720
a=14.4553(13)Å b=8.7501(9)Å c=16.8630(16)Å
α=90° β=119.696(6)° γ=90°
2-(4-Chlorophenyl)-4-phenyl-1,2-dihydroquinazoline
C20H15ClN2
Acta Crystallographica Section E (2013) 69, 11 o1653-o1654
a=9.2563(10)Å b=10.6283(11)Å c=17.6230(19)Å
α=90° β=116.775(7)° γ=90°
4-(2-Nitrobenzyl)-3-phenyl-3,4-dihydro-2<i>H</i>-1,4-benzoxazin-2-ol
C21H18N2O4
Acta Crystallographica Section E (2014) 70, 8 o863-o864
a=12.7332(14)Å b=14.2777(14)Å c=19.003(2)Å
α=90° β=90° γ=90°